Advisory OTCs? GSK Discusses “Third Class” Drug Paradigm, But Xenical Not Included
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK Consumer Healthcare’s Regnier says firm is discussing pharmacy-only class internally but has yet to take a formal stance on the issue. Any switch of the weight-loss drug orlistat would occur within the existing two-class system, the company says.